This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (464)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Diabetes Mellitus  • Alert me on articles by topic

Hertzel C. Gerstein, MD,MSc; Johannes F. E. Mann, MD; Qilong Yi, PhD; Bernard Zinman, MD,CM; Sean F. Dinneen, MD,MSc; Byron Hoogwerf, MD; Jean Pierre Hallé, MD; James Young, MD; Andrew Rashkow, MD; Carol Joyce, MD; Shah Nawaz, MD; Salim Yusuf, MBBS,DPhil; for the HOPE Study Investigators

JAMA. 2001;286:421-426.

Context  Microalbuminuria is a risk factor for cardiovascular (CV) events. The relationship between the degree of albuminuria and CV risk is unclear.

Objectives  To estimate the risk of CV events in high-risk individuals with diabetes mellitus (DM) and without DM who have microalbuminuria and to determine whether levels of albuminuria below the microalbuminuria threshold increase CV risk.

Design  The Heart Outcomes Prevention Evaluation study, a cohort study conducted between 1994 and 1999 with a median 4.5 years of follow-up.

Setting  Community and academic practices in North and South America and Europe.

Participants  Individuals aged 55 years or more with a history of CV disease (n = 5545) or DM and at least 1 CV risk factor (n = 3498) and a baseline urine albumin/creatinine ratio (ACR) measurement.

Main Outcome Measures  Cardiovascular events (myocardial infarction, stroke, or CV death); all-cause death; and hospitalization for congestive heart failure.

Results  Microalbuminuria was detected in 1140 (32.6%) of those with DM and 823 (14.8%) of those without DM at baseline. Microalbuminuria increased the adjusted relative risk (RR) of major CV events (RR, 1.83; 95% confidence interval [CI], 1.64-2.05), all-cause death (RR, 2.09; 95% CI, 1.84-2.38), and hospitalization for congestive heart failure (RR, 3.23; 95% CI, 2.54-4.10). Similar RRs were seen for participants with or without DM, even after adjusting for other CV risk factors (eg, the adjusted RR of the primary aggregate end point was 1.97 [95% CI, 1.68-2.31] in those with DM and 1.61 [95% CI, 1.36-1.90] in those without DM).Compared with the lowest quartile of ACR (<0.22 mg/mmol), the RRs of the primary aggregate end point in the second quartile (ie, ACR range, 0.22-0.57 mg/mmol) was 1.11 (95% CI, 0.95-1.30); third quartile, 1.38 (95% CI, 1.19-1.60; ACR range, 0.58-1.62 mg/mmol); and fourth quartile, 1.97 (95% CI, 1.73-2.25; ACR range, >1.62 mg/mmol) (P for trend <.001, even after excluding those with microalbuminuria). For every 0.4-mg/mmol increase in ACR level, the adjusted hazard of major CV events increased by 5.9% (95% CI, 4.9%-7.0%).

Conclusions  Our results indicate that any degree of albuminuria is a risk factor for CV events in individuals with or without DM; the risk increases with the ACR, starting well below the microalbuminuria cutoff. Screening for albuminuria identifies people at high risk for CV events.

Author Affiliations: McMaster University, Hamilton, Ontario (Drs Gerstein, Yi, and Yusuf); Klinikum Schwabing, LMU, Munich, Germany (Dr Mann); Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario (Dr Zinman); Addenbrookes Hospital, Cambridge, England (Dr Dinneen); Cleveland Clinic Foundation, Cleveland, Ohio (Drs Hoogwerf and Young); Université de Montréal, Montréal, Québec (Dr Hallé); Griffin Hospital, Derby, Conn (Dr Rashkow); Memorial University, St John's, Newfoundland (Dr Joyce); and Sudbury Regional Hospital, Sudbury, Ontario (Dr Nawaz).

RELATED ARTICLE

July 25, 2001
JAMA. 2001;286(4):479-480.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glomerular Filtration Rate, Albuminuria, and Risk of Cardiovascular and All-Cause Mortality in the US Population
Astor et al.
Am J Epidemiol 2008;167:1226-1234.
ABSTRACT | FULL TEXT  

Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Schocken et al.
Circulation 2008;117:2544-2565.
ABSTRACT | FULL TEXT  

Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
Bahrami et al.
J Am Coll Cardiol 2008;51:1775-1783.
ABSTRACT | FULL TEXT  

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality
Suliman et al.
QJM 2008;101:397-405.
ABSTRACT | FULL TEXT  

Relation of Low Glomerular Filtration Rate to Metabolic Disorders in Individuals without Diabetes and with Normoalbuminuria
Lorenzo et al.
CJASN 2008;3:783-789.
ABSTRACT | FULL TEXT  

Association of Albuminuria and Cancer Incidence
Jorgensen et al.
J. Am. Soc. Nephrol. 2008;19:992-998.
ABSTRACT | FULL TEXT  

Telemedicine Home Blood Pressure Measurements and Progression of Albuminuria in Elderly People With Diabetes
Palmas et al.
Hypertension 2008;51:1282-1288.
ABSTRACT | FULL TEXT  

Predictors of new-onset decline in kidney function in a general middle-european population
Obermayr et al.
Nephrol Dial Transplant 2008;23:1265-1273.
ABSTRACT | FULL TEXT  

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA
Palmer et al.
Nephrol Dial Transplant 2008;23:1216-1223.
ABSTRACT | FULL TEXT  

Development and Validation of an All-Cause Mortality Risk Score in Type 2 Diabetes: The Hong Kong Diabetes Registry
Yang et al.
Arch Intern Med 2008;168:451-457.
ABSTRACT | FULL TEXT  

Cardiovascular Literature--Beyond Nephrology
Ritz
CJASN 2008;3:317-323.
FULL TEXT  

Medical Treatment of Advanced Testicular Cancer
Feldman et al.
JAMA 2008;299:672-684.
ABSTRACT | FULL TEXT  

Microalbuminuria in Type 2 Diabetes and Hypertension: A marker, treatment target, or innocent bystander?
Basi et al.
Diabetes Care 2008;31:S194-S201.
FULL TEXT  

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Rosamond et al.
Circulation 2008;117:e25-e146.
FULL TEXT  

Mild renal dysfunction associated with incident coronary artery disease in young males
Pereg et al.
Eur Heart J 2008;29:198-203.
ABSTRACT | FULL TEXT  

Evaluation of renal function in leprosy: a study of 59 consecutive patients
Oliveira et al.
Nephrol Dial Transplant 2008;23:256-262.
ABSTRACT | FULL TEXT  

Renal Insufficiency and Mortality in Patients with Known or Suspected Coronary Artery Disease
van Domburg et al.
J. Am. Soc. Nephrol. 2008;19:158-163.
ABSTRACT | FULL TEXT  

Being Overweight Modifies the Association Between Cardiovascular Risk Factors and Microalbuminuria in Adolescents
Nguyen et al.
Pediatrics 2008;121:37-45.
ABSTRACT | FULL TEXT  

Influence of Albuminuria on Cardiovascular Risk in Patients With Stable Coronary Artery Disease
Solomon et al.
Circulation 2007;116:2687-2693.
ABSTRACT | FULL TEXT  

Change in Albuminuria Is Predictive of Cardiovascular Outcome in Normotensive Patients With Type 2 Diabetes and Microalbuminuria
Zandbergen et al.
Diabetes Care 2007;30:3119-3121.
FULL TEXT  

Diabetes, the Metabolic Syndrome, and Ischemic Stroke: Epidemiology and possible mechanisms
Air and Kissela
Diabetes Care 2007;30:3131-3140.
FULL TEXT  

Review: Renin-angiotensin-aldosterone system intervention in the cardiometabolic syndrome and cardio-renal protection
Whaley-Connell et al.
Therapeutic Advances in Cardiovascular Disease 2007;1:27-35.
ABSTRACT  

Screening for Coronary Artery Disease in Patients With Diabetes
Bax et al.
Diabetes Care 2007;30:2729-2736.
ABSTRACT | FULL TEXT  

Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension
Salles et al.
Hypertension 2007;50:723-728.
ABSTRACT | FULL TEXT  

How common is early chronic kidney disease?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease
MacGregor
Nephrol Dial Transplant 2007;22:ix8-ix18.
FULL TEXT  

Are Patients Who Have Metabolic Syndrome without Diabetes at Risk for Developing Chronic Kidney Disease? Evidence Based on Data from a Large Cohort Screening Population
Rashidi et al.
CJASN 2007;2:976-983.
ABSTRACT | FULL TEXT  

Exacerbation of Albuminuria and Renal Fibrosis in Subtotal Renal Ablation Model of Adiponectin-Knockout Mice
Ohashi et al.
Arterioscler. Thromb. Vasc. Bio. 2007;27:1910-1917.
ABSTRACT | FULL TEXT  

Albuminuria and Risk of Nonvertebral Fractures
Jorgensen et al.
Arch Intern Med 2007;167:1379-1385.
ABSTRACT | FULL TEXT  

Cross-Classification of Microalbuminuria and Reduced Glomerular Filtration Rate: Associations Between Cardiovascular Disease Risk Factors and Clinical Outcomes
Foster et al.
Arch Intern Med 2007;167:1386-1392.
ABSTRACT | FULL TEXT  

Chronic Kidney Disease: Effects on the Cardiovascular System
Schiffrin et al.
Circulation 2007;116:85-97.
ABSTRACT | FULL TEXT  

Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men
Ingelsson et al.
Eur Heart J 2007;28:1739-1745.
ABSTRACT | FULL TEXT  

The Unique Character of Cardiovascular Disease in Chronic Kidney Disease and Its Implications for Treatment with Lipid-Lowering Drugs
Nogueira and Weir
CJASN 2007;2:766-785.
ABSTRACT | FULL TEXT  

Central Obesity Is an Independent Risk Factor for Albuminuria in Nondiabetic South Asian Subjects
Chandie Shaw et al.
Diabetes Care 2007;30:1840-1844.
ABSTRACT | FULL TEXT  

Pharmacoeconomic Analysis of Angiotensin-Converting Enzyme Inhibitors in Type 2 Diabetes: A Markov Model
Campbell et al.
The Annals of Pharmacotherapy 2007;41:1101-1110.
ABSTRACT | FULL TEXT  

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT  

Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin
Ozsoy et al.
Nephrol Dial Transplant 2007;22:1578-1586.
ABSTRACT | FULL TEXT  

Reduction in Microalbuminuria as an Integrated Indicator for Renal and Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
Araki et al.
Diabetes 2007;56:1727-1730.
ABSTRACT | FULL TEXT  

Estimated Glomerular Filtration Rate and Urinary Albumin Excretion Are Independently Associated with Greater Arterial Stiffness: The Hoorn Study
Hermans et al.
J. Am. Soc. Nephrol. 2007;18:1942-1952.
ABSTRACT | FULL TEXT  

Microalbuminuria and Cardiovascular Disease
Weir
CJASN 2007;2:581-590.
ABSTRACT | FULL TEXT  

Subclinical Cardiovascular Disease Markers Applicable to Studies of Oral Health: Multiethnic Study of Atherosclerosis
JACOBS and CROW
Ann. N. Y. Acad. Sci. 2007;1098:269-287.
ABSTRACT | FULL TEXT  

Albuminuria as risk factor for initiation and progression of carotid atherosclerosis in non-diabetic persons: the Tromso Study
Jorgensen et al.
Eur Heart J 2007;28:363-369.
ABSTRACT | FULL TEXT  

What Predicts Progression and Regression of Urinary Albumin Excretion in the Nondiabetic Population?
Brantsma et al.
J. Am. Soc. Nephrol. 2007;18:637-645.
ABSTRACT | FULL TEXT  

What's new in hypertension?
Mann
Nephrol Dial Transplant 2007;22:47-52.
FULL TEXT  

Development and Validation of Stroke Risk Equation for Hong Kong Chinese Patients With Type 2 Diabetes: The Hong Kong Diabetes Registry
Yang et al.
Diabetes Care 2007;30:65-70.
ABSTRACT | FULL TEXT  

Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang et al.
NEJM 2006;355:2631-2639.
ABSTRACT | FULL TEXT  

Prevalence of Abnormal Urinary Albumin Excretion Rate in Hypertensive Patients with Impaired Fasting Glucose and Its Association with Cardiovascular Disease
Marin et al.
J. Am. Soc. Nephrol. 2006;17:S178-S188.
ABSTRACT | FULL TEXT  

Urinary Albumin Excretion and Glomerular Filtration Rate across the Spectrum of Glucose Abnormalities in Essential Hypertension
Redon et al.
J. Am. Soc. Nephrol. 2006;17:S236-S245.
ABSTRACT | FULL TEXT  

Does urinary tract infection cause proteinuria or microalbuminuria? A systematic review
Carter et al.
Nephrol Dial Transplant 2006;21:3031-3037.
FULL TEXT  

Predictors of Angiotensin-Converting Enzyme Inhibitor-Induced Reduction of Urinary Albumin Excretion in Nondiabetic Patients
van de Wal et al.
Hypertension 2006;48:870-876.
ABSTRACT | FULL TEXT  

Evaluation of Measures of Urinary Albumin Excretion
Gansevoort et al.
Am J Epidemiol 2006;164:725-727.
ABSTRACT | FULL TEXT  

Micro- and macroalbuminuria predict hemorrhagic transformation in acute ischemic stroke.
Rodriguez-Yanez et al.
Neurology 2006;67:1172-1177.
ABSTRACT | FULL TEXT  

Association of low-grade urinary albumin excretion with left ventricular hypertrophy in the general population: The MONICA/KORA Augsburg Echocardiographic Substudy
Lieb et al.
Nephrol Dial Transplant 2006;21:2780-2787.
ABSTRACT | FULL TEXT  

Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
Sarafidis and Bakris
Nephrol Dial Transplant 2006;21:2366-2374.
FULL TEXT  

Macroalbuminuria Is a Better Risk Marker than Low Estimated GFR to Identify Individuals at Risk for Accelerated GFR Loss in Population Screening
Halbesma et al.
J. Am. Soc. Nephrol. 2006;17:2582-2590.
ABSTRACT | FULL TEXT  

Microalbuminuria and Risk for Cardiovascular Disease: Analysis of Potential Mechanisms
Stehouwer and Smulders
J. Am. Soc. Nephrol. 2006;17:2106-2111.
ABSTRACT | FULL TEXT  

Cross-Talk between the Kidney and the Cardiovascular System
Amann et al.
J. Am. Soc. Nephrol. 2006;17:2112-2119.
ABSTRACT | FULL TEXT  

Microalbuminuria as an Early Marker for Cardiovascular Disease
de Zeeuw et al.
J. Am. Soc. Nephrol. 2006;17:2100-2105.
ABSTRACT | FULL TEXT  

Ambulatory Pulse Pressure and Progression of Urinary Albumin Excretion in Older Patients With Type 2 Diabetes Mellitus
Palmas et al.
Hypertension 2006;48:301-308.
ABSTRACT | FULL TEXT  

Meta-Analysis: The Effect of Statins on Albuminuria
Douglas et al.
ANN INTERN MED 2006;145:117-124.
ABSTRACT | FULL TEXT  

Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study
Blankenberg et al.
Circulation 2006;114:201-208.
ABSTRACT | FULL TEXT  

Managing hypertension in patients with type 2 diabetes mellitus.
Dobesh
Am J Health Syst Pharm 2006;63:1140-1149.
ABSTRACT | FULL TEXT  

Pulsatility index at the cervical internal carotid artery as a parameter of microangiopathy in patients with type 2 diabetes.
Fukuhara and Hida
J Ultrasound Med 2006;25:599-605.
ABSTRACT | FULL TEXT  

Office and Ambulatory Blood Pressure Are Independently Associated With Albuminuria in Older Subjects With Type 2 Diabetes
Moran et al.
Hypertension 2006;47:955-961.
ABSTRACT | FULL TEXT  

Influence of Proteinuria on Cardiovascular Risk and Response to Angiotensin-Converting Enzyme Inhibition After Myocardial Infarction
Jose et al.
J Am Coll Cardiol 2006;47:1725-1727.
FULL TEXT  

Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
Segura et al.
J. Am. Soc. Nephrol. 2006;17:S136-S140.
ABSTRACT | FULL TEXT  

Randomized Clinical Trials on Surrogate End Points: Are They Useful for Evaluating Cardiovascular and Renal Disease Protection in Hypertension? The Case for Yes
Morganti
J. Am. Soc. Nephrol. 2006;17:S141-S144.
ABSTRACT | FULL TEXT  

Lipids and Renal Disease
Trevisan et al.
J. Am. Soc. Nephrol. 2006;17:S145-S147.
ABSTRACT | FULL TEXT  

Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes
Gilbert et al.
CJASN 2006;1:193-208.
ABSTRACT | FULL TEXT  

Renal Function and Outcome From Coronary Artery Bypass Grafting: Impact on Mortality After a 2.3-Year Follow-Up
Hillis et al.
Circulation 2006;113:1056-1062.
ABSTRACT | FULL TEXT  

Update in nephrology and hypertension.
Kimmel
ANN INTERN MED 2006;144:281-285.
FULL TEXT  

Role of Diminished Renal Function in Cardiovascular Mortality: Marker or Pathogenetic Factor?
Schrier
J Am Coll Cardiol 2006;47:1-8.
ABSTRACT | FULL TEXT  

Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment
Berl and Henrich
CJASN 2006;1:8-18.
FULL TEXT  

Preserving cardiac function in the hypertensive patient: why renal parameters hold the key
Montalescot and Collet
Eur Heart J 2005;26:2616-2622.
ABSTRACT | FULL TEXT  

Reduction of Microalbuminuria by {beta} Blockers: Beyond Renin-Angiotensin System Blockade
Ritz
Hypertension 2005;46:1254-1255.
FULL TEXT  

Direct, Progressive Association of Cardiovascular Risk Factors With Incident Proteinuria: Results From the Korea Medical Insurance Corporation (KMIC) Study
Jee et al.
Arch Intern Med 2005;165:2299-2304.
ABSTRACT | FULL TEXT  

The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial
Gupta et al.
Nephrol Dial Transplant 2005;20:2237-2242.
ABSTRACT | FULL TEXT  

Antihypertensive Agents for Primary Prevention of Diabetic Nephropathy
Strippoli et al.
J. Am. Soc. Nephrol. 2005;16:3081-3091.
ABSTRACT | FULL TEXT  

Kidney and Blood Pressure--The Story Unfolds: Renalase Is a Novel, Soluble Monoamine Oxidase That Regulates Cardiac Function and Blood Pressure. J Clin Invest
J et al.
J. Am. Soc. Nephrol. 2005;16:2521-2527.
FULL TEXT  

Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study
Arnlov et al.
Circulation 2005;112:969-975.
ABSTRACT | FULL TEXT  

Anorexia and Cachexia in Renal Failure--Is Leptin the Culprit?: Role of Leptin and Melanocortin Signaling in Uremia-Associated Cachexia. J Clin Invest 115: 1659-1665, 2005
W et al.
J. Am. Soc. Nephrol. 2005;16:2245-2250.
FULL TEXT  

Cost-Effectiveness of Full Medicare Coverage of Angiotensin-Converting Enzyme Inhibitors for Beneficiaries with Diabetes
Rosen et al.
ANN INTERN MED 2005;143:89-99.
ABSTRACT | FULL TEXT  

Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial
Berl et al.
J. Am. Soc. Nephrol. 2005;16:2170-2179.
ABSTRACT | FULL TEXT  

Urinary Albumin Excretion: Lowering the Threshold of Risk in Hypertension
Redon
Hypertension 2005;46:19-20.
FULL TEXT  

New Definition of Microalbuminuria in Hypertensive Subjects: Association With Incident Coronary Heart Disease and Death
Klausen et al.
Hypertension 2005;46:33-37.
ABSTRACT | FULL TEXT  

Urine Albumin Excretion and Subclinical Cardiovascular Disease
Kramer et al.
Hypertension 2005;46:38-43.
ABSTRACT | FULL TEXT  

Chronic kidney disease as cause of cardiovascular morbidity and mortality
Vanholder et al.
Nephrol Dial Transplant 2005;20:1048-1056.
ABSTRACT | FULL TEXT  

Albumin Excretion Rate and Cardiovascular Risk: Could the Association Be Explained by Early Microvascular Dysfunction?
Strain et al.
Diabetes 2005;54:1816-1822.
ABSTRACT | FULL TEXT  

Long-Term Impact of Systolic Blood Pressure and Glycemia on the Development of Microalbuminuria in Essential Hypertension
Pascual et al.
Hypertension 2005;45:1125-1130.
ABSTRACT | FULL TEXT  

Renal manifestations of the metabolic syndrome
Tuttle
Nephrol Dial Transplant 2005;20:861-864.
FULL TEXT  

Amelioration of Acute Renal Failure by Stem Cell Therapy--Paracrine Secretion Versus Transdifferentiation into Resident Cells: Administered Mesenchymal Stem Cells Protect against Ischemic Acute Renal Failure through Differentiation-Independent Mechanisms. Am J Physiol Renal Physiol E-pub February 15, 2005
Togel et al.
J. Am. Soc. Nephrol. 2005;16:1153-1163.
FULL TEXT